TBIO 2.60 Transgenomic Inc $TBIO Hit a 52 week low of 2.39

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
TBIO 2.60 Transgenomic Inc $TBIO Hit a 52 week low of 2.39 Currently at 2.60 -0.02 -0.76% With a day low of 2.39 and a total volume of 34,200.

TBIO Transgenomic Inc Recent Headline News

Transgenomic Announces Executive Changes
Business Wire - Wed Nov 05, 7:30AM CST
Transgenomic, Inc. (NASDAQ:TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced certain executive management changes. Mark Colonnese, the Chief Financial Officer and Executive Vice President of Transgenomic, resigned from the Company effective October 30, 2014. Paul Kinnon, Transgenomic's President and Chief Executive Officer, will assume the role of Interim Chief Financial Officer. Additionally, Leon Richards, Transgenomic's Corporate Controller, will take on additional responsibilities as Chief Accounting Officer for Transgenomic.
TBIO: 2.60 (-0.02)

Transgenomic Reports Third Quarter 2014 Financial Results
Business Wire - Thu Oct 30, 6:02AM CDT
Transgenomic, Inc. (NASDAQ:TBIO) today reported financial results for the third quarter ended September 30, 2014, and provided a business update.
TBIO: 2.60 (-0.02)

Transgenomic and University of Melbourne Collaborate to Further Validate Ability of Multiplexed ICE COLD-PCR(TM) to Enable Personalized Cancer Treatment
Business Wire - Thu Oct 30, 6:00AM CDT
--MX-ICP Technology Enables Ultra-Sensitive Detection and Monitoring of Multiple Known and Unknown Cancer Mutations in a Single Assay Using Tumor Biopsy or Blood
TBIO: 2.60 (-0.02)

Transgenomic to Hold Third Quarter Financial Results Conference Call on October 30, 2014 at 8:30AM ET
Business Wire - Thu Oct 23, 6:00AM CDT
Transgenomic, Inc. (NASDAQ: TBIO), today announced that the company will hold its Third Quarter 2014 Financial Results and Business Update Conference Call on Thursday, October 30, 2014 at 8:30 AM ET.
TBIO: 2.60 (-0.02)

Transgenomic Announces $2.375 Million Private Placement Financing
Business Wire - Wed Oct 22, 3:06PM CDT
Transgenomic, Inc. (NASDAQ: TBIO) announced today that it has raised gross proceeds of approximately $2.375 million in a private placement financing with a syndicate of new and existing institutional and other accredited investors. The Company's common shares were priced at $3.25 per share, which represents a premium to the closing stock price on October 21, 2014. For each share of common stock purchased, investors also received a warrant to purchase 0.5 shares of the Company's common stock at an exercise price of $4.00 per share. The warrants have a term of exercise equal to five years from the first date of exercise, which is six months following the closing date. In the aggregate, the Company issued approximately 0.73 million shares of common stock and 0.37 million warrants.
TBIO: 2.60 (-0.02)

Transgenomic to Present at BTIG Emerging Technologies in Healthcare Diagnostics Conference
Business Wire - Wed Sep 24, 6:00AM CDT
Transgenomic, Inc. (NASDAQ:TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that senior management will participate in the BTIG Emerging Technologies in Healthcare Diagnostics conference. Transgenomic's Executive Vice President and Chief Financial Officer Mark Colonnese will discuss Personalized Medicine in the CLIA Lab on Monday, September 29, 2014 at 4:10 pm ET.
TBIO: 2.60 (-0.02)

Transgenomic to Present at Fifth Annual Craig-Hallum Alpha Select Conference
Business Wire - Mon Sep 15, 10:00AM CDT
Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that senior management will give a corporate presentation at the Fifth Annual Craig-Hallum Alpha Select Conference being held at the Convene Conference Center in New York City. Transgenomic's Executive Vice President and Chief Financial Officer Mark Colonnese will present on Thursday, September 18,2014 at 8:40 am ET.
TBIO: 2.60 (-0.02)

Transgenomic to Present at Rodman & Renshaw 16th Annual Global Investment Conference
Business Wire - Fri Sep 05, 6:00AM CDT
Transgenomic, Inc. (NASDAQ:TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that senior management will give a corporate presentation at the Rodman & Renshaw 16th Annual Global Investment Conference being held at the New York Palace Hotel in New York City. Transgenomic will present on Wednesday, September 10, 2014 at 11:15 am ET. Transgenomic Chief Executive Officer Paul Kinnon and Chief Financial Officer Mark Colonnese will participate.
TBIO: 2.60 (-0.02)

Transgenomic Reports Second Quarter 2014 Financial Results
Business Wire - Wed Aug 06, 3:06PM CDT
Transgenomic, Inc. (NASDAQ:TBIO) today reported financial results for the second quarter ended June 30, 2014, and provided a business update.
TBIO: 2.60 (-0.02)

Reminder: Transgenomic to Hold Second Quarter Financial Results Conference Call Today
Business Wire - Wed Aug 06, 6:00AM CDT
Transgenomic, Inc. (NASDAQ: TBIO) today announced the following Webcast:
TBIO: 2.60 (-0.02)

Transgenomic Announces Issuance of New European Patent Covering COLD-PCR Technologies
Business Wire - Thu Jul 31, 6:00AM CDT
Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that the European Patent Office has issued a new patent, European Patent No. 21833798, covering one of its COLD-PCR family of DNA amplification technologies. The patent covers Full COLD-PCR, a foundation for the company's highly sensitive ICE COLD-PCR technology. The COLD-PCR technology is owned by the Dana-Farber Cancer Institute, Boston USA, and exclusively licensed to Transgenomic.
TBIO: 2.60 (-0.02)

Transgenomic to Hold Second Quarter Financial Results Conference Call on August 6, 2014
Business Wire - Wed Jul 30, 3:30PM CDT
Transgenomic, Inc. (NASDAQ:TBIO) today announced the following Webcast:
TBIO: 2.60 (-0.02)

Transgenomic Sells Rights to SURVEYOR Mutation Detection Technology and Assets to Integrated DNA Technologies, Inc.
Business Wire - Wed Jul 02, 6:00AM CDT
Transgenomic, Inc. (NASDAQ:TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that it has entered into an agreement to sell to Integrated DNA Technologies, Inc. (IDT) the rights to Transgenomic's SURVEYOR Nuclease technology and assets for a minimum of $4.25 million. SURVEYOR Mutation Detection Kits provide researchers with a simple, robust and versatile method to detect mutations and polymorphisms in DNA from a variety of organisms.
TBIO: 2.60 (-0.02)

Dr. Michael A. Luther Joins Transgenomic's Board of Directors
Business Wire - Wed Mar 19, 6:00AM CDT
Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced the appointment of Michael A. Luther, Ph.D., to its Board of Directors. Dr. Luther will also become a member of the Board's audit committee. His appointment became effective March 13, 2014.
TBIO: 2.60 (-0.02)

Transgenomic Reports Fourth Quarter and Fiscal Year 2013 Financial Results
Business Wire - Wed Mar 12, 3:10PM CDT
Transgenomic, Inc. (OTC/BB: TBIO) today reported financial results for the fourth quarter and year ended December 31, 2013, and provided a business update.
TBIO: 2.60 (-0.02)

Reminder: Transgenomic to Hold Fourth Quarter Financial Results Conference Call Today
Business Wire - Wed Mar 12, 7:44AM CDT
Transgenomic, Inc. (OTC/BB: TBIO) today announced the following Webcast:
TBIO: 2.60 (-0.02)

Transgenomic to Hold Fourth Quarter Financial Results Conference Call on March 12, 2014
Business Wire - Thu Mar 06, 10:51AM CST
Transgenomic, Inc. (OTC/BB: TBIO) today announced the following Webcast:
TBIO: 2.60 (-0.02)

Transgenomic Announces $7 Million Convertible Preferred Stock Financing
Business Wire - Thu Mar 06, 6:30AM CST
Transgenomic, Inc. (OTCBB:TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced that it has entered into an agreement with affiliates of Third Security, LLC ("Third Security" , a leading life sciences investment firm founded by R.J. Kirk, to sell to them 1,443,297 million Series B convertible preferred shares at a price of $4.85 per share for gross proceeds of $7.0 million.
TBIO: 2.60 (-0.02)

Barrick Announces Agreement to Divest its Minority Interest in Marigold in Nevada
Marketwire - Tue Feb 04, 12:11AM CST
All amounts expressed in US dollars unless otherwise indicated.
ABT: 43.37 (-0.32), ABX.TO: 13.79 (+0.82), ABX: 12.16 (+0.82), TBIO: 2.60 (-0.02), DGX: 61.69 (-1.07), SSRI: 5.20 (+0.88), PKI: 43.81 (-0.85)

OTC Daily Alert Stock Watch - Transgenomic, Inc. (OTCQB: TBIO)
WorldStockWire - Thu Sep 05, 4:15PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
TBIO: 2.60 (-0.02)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Thanksgiving Dog Safety Is a Pet Care Reality Check

Updated Category News Views 0

A crowded Thanksgiving kitchen can turn a well-behaved dog into a scavenger with lousy odds. Camp Bow Wow’s holiday guidance is not pretending the meal itself is the problem; the trouble is that a house full of distracted people, rich food and unsecured trash creates a pile of easy mistakes. For pet owners, that is a fair reminder. For anybody watching the pet-care...

Continue Reading
Peptide Labels Cannot Substitute for Clinical Care

Updated Category News Views 9

A Label Is Not a Care Plan Those three little words, research use only, carry far more weight than a flashy product page would have people believe. The HelloNation article featuring wellness expert Andres Giraldo makes a plain but necessary distinction: a research-use-only, or RUO, label does not turn a peptide into prescribed treatment, and it sure does not establish...

Continue Reading
Washington-to-Asia Advisory Deal Targets Policy Risk

Updated Category News Views 0

Policy bottlenecks are becoming a cost center across Southeast Asia. That is the plain-English backdrop for the strategic partnership announced November 18, 2026, by Beacon Global Strategies and Vriens & Partners. Neither firm is selling a factory, a chip design, or a new energy project. They are selling something companies increasingly cannot afford to improvise: a...

Continue Reading
Spruce Spins Adrenyx En Route to Nasdaq in 2027

Updated Category News Views 206

New Frontiers: Adrenyx Biosciences Takes Shape Well, here's a new chapter in biotech drama. Spruce Biosciences, a name you might have tangled with if you're into tickers like NASDAQ:SPRB, just carved out a niche with the birth of Adrenyx Biosciences. The play? A separate company eyeing the endocrinology space, setting its sights on tackling congenital adrenal hyperplasia...

Continue Reading
Tactical Tomahawk Motor Deal Puts Propulsion in Focus

Updated Category News Views 31

A missile program lives or dies on unglamorous hardware, and solid rocket motors are about as unglamorous as it gets until somebody cannot build enough of them. Raytheon has awarded Ursa Major and Avio USA a joint contract to develop solid rocket motors for the U.S. Navy’s Tactical Tomahawk missile program. That is the whole headline, and it matters more than the thin...

Continue Reading
Insider Risk Makes Human Judgment a Security Priority

Updated Category News Views 127

A badge, a password, and a locked gate can all look reassuring right up until the person holding them starts to crack. Signpost Six's new report, The Psychology of Insider Risk, lands on an uncomfortable truth: the most consequential security weakness may not be a system at all. It may be an employee under strain, in conflict, in debt, making a mistake, or being quietly...

Continue Reading
Google Search Data Sharing Faces a Privacy Reality Check

Updated Category News Views 91

Search queries are messy little confessions, and that is exactly why this case deserves more than a bureaucratic shrug. Woodway Assurance's independent assessment says Google's search-query data could be treated as anonymized for sharing under the Digital Markets Act, but only if the European Commission tightens parts of its July 2026 framework. That is not a clean bill...

Continue Reading
Kawneer’s OptiQ Window Wins a Useful Design Signal

Updated Category News Views 49

Three Nods, One Very Practical Product Claim Windows rarely stir much excitement outside an architect’s specification binder, but Kawneer has put together a respectable run with its OptiQ Offset Fixed/Projected Series Window. On November 18, 2026, the architectural aluminum-systems maker said the product had won in the Windows and Doors category at both the 2026...

Continue Reading
A Decade of Giving: Light the World Initiative's Impact

Updated Category News Views 157

The Red Kiosk Revolution It's not every day that a church initiative pops up in global conversations, but here we are—ten years into the Light the World initiative by The Church of Jesus Christ of Latter-day Saints. What's interesting is how these little kiosks, like silent ambassadors, have become a staple in 145 spots this holiday season, spanning continents. Each...

Continue Reading
Anycubic Pushes Toward a Smoother 3D Printing Ecosystem

Updated Category News Views 46

Friction Is the Enemy in Consumer 3D Printing A printer that makes a beautiful object only after three failed attempts is not a consumer product; it is a weekend argument with plastic. That is the useful lens for Anycubic's Formnext 2026 showing in Frankfurt on November 18. The company is not merely rolling out FDM and resin machines at Booth F01 in Hall 12.0. It is...

Continue Reading

Top 5 Most Recently Viewed Articles

AbbVie's Options Activity: Understanding the Market Trends

Updated Category News Views 188

Understanding AbbVie’s Recent Options Activity Recently, there has been a notable shift in the options trading landscape surrounding AbbVie (NYSE: ABBV). Investors with significant capital seem to be leaning towards a bearish outlook regarding AbbVie. This movement in options trading is particularly important for retail traders to consider. What’s Behind the Trading...

Continue Reading
Innovative Trends at Spielwarenmesse: A Toy Industry Showcase

Updated Category News Views 271

Exploring the Spielwarenmesse: The Ultimate Toy Expo The Spielwarenmesse has established itself as a pivotal platform for the global toy industry. Showcasing creativity, innovation, and networking opportunities, this event gathers notable participants from across the toy spectrum. Diverse Exhibitors and Cutting-Edge Innovations With over 2,362 exhibitors representing 71...

Continue Reading
Nota AI and Renesas: Revolutionizing Driver Monitoring Technology

Updated Category News Views 173

Collaboration Between Nota AI and Renesas Nota AI, known for its expertise in AI optimization, has announced an exciting partnership with Renesas Electronics Corporation, aiming to advance driver monitoring technology through the optimized Driver Monitoring System (DMS). This collaboration is particularly focused on the new RA8P1 microcontroller unit (MCU), which is...

Continue Reading
Bureau Veritas Expands in Renewables with ArcVera Acquisition

Updated Category News Views 74

Bureau Veritas Expands in the Renewable Energy Sector Bureau Veritas, a global leader in testing, inspection, and certification services, has recently made a significant move by acquiring ArcVera Renewables. This strategic acquisition aims to strengthen Bureau Veritas's position in the fast-growing renewable energy sector across North America. Strategic Alignment with...

Continue Reading
Understanding T. Rowe Price Group's Earnings Expectations

Updated Category News Views 170

Anticipating T. Rowe Price Group's Earnings Announcement T. Rowe Price Gr (TROW) is poised to announce its quarterly earnings soon. Investors are keenly focused on the impending announcement, hoping for positive results that exceed expectations. As the company prepares for the reporting date, understanding what to anticipate can be essential for informed investment...

Continue Reading